| Nome |
# |
|
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus, file dfa8b990-8481-748b-e053-3a05fe0a3a96
|
518
|
|
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure., file dfa8b9a0-4053-748b-e053-3a05fe0a3a96
|
378
|
|
Sex-Specific Features of Microglia from Adult Mice, file dfa8b99b-be78-748b-e053-3a05fe0a3a96
|
284
|
|
Dendritic spines in alzheimer’s disease : How the actin cytoskeleton contributes to synaptic failure, file dfa8b9a2-8635-748b-e053-3a05fe0a3a96
|
265
|
|
Modeling Alzheimer's disease: from past to future, file dfa8b991-3c36-748b-e053-3a05fe0a3a96
|
255
|
|
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker, file dfa8b99d-de96-748b-e053-3a05fe0a3a96
|
237
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file dfa8b99e-0441-748b-e053-3a05fe0a3a96
|
197
|
|
Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia : three faces of the same coin, file dfa8b999-e0bb-748b-e053-3a05fe0a3a96
|
184
|
|
Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus, file dfa8b994-fb2d-748b-e053-3a05fe0a3a96
|
162
|
|
SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation, file dfa8b991-dfa7-748b-e053-3a05fe0a3a96
|
135
|
|
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex, file dfa8b994-0b8e-748b-e053-3a05fe0a3a96
|
134
|
|
Lack of the Actin Capping Protein, Eps8, Affects NMDA-Type Glutamate Receptor Function and Composition, file dfa8b99c-25af-748b-e053-3a05fe0a3a96
|
132
|
|
Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons, file dfa8b998-300b-748b-e053-3a05fe0a3a96
|
130
|
|
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition, file dfa8b99f-613d-748b-e053-3a05fe0a3a96
|
117
|
|
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability, file dfa8b9a3-7b96-748b-e053-3a05fe0a3a96
|
115
|
|
Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic fibroblasts, file dfa8b9a5-9955-748b-e053-3a05fe0a3a96
|
110
|
|
A light-gated potassium channel for sustained neuronal inhibition, file dfa8b99c-c95e-748b-e053-3a05fe0a3a96
|
107
|
|
The Epilepsy-Related Protein PCDH19 Regulates Tonic Inhibition, GABA A R Kinetics, and the Intrinsic Excitability of Hippocampal Neurons, file dfa8b9a3-7c1f-748b-e053-3a05fe0a3a96
|
106
|
|
Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease, file dfa8b9a4-b467-748b-e053-3a05fe0a3a96
|
100
|
|
CAPt’n of Actin Dynamics: Recent Advances in the Molecular, Developmental and Physiological Functions of Cyclase-Associated Protein (CAP), file dfa8b9a4-9a2f-748b-e053-3a05fe0a3a96
|
91
|
|
Adam10 plasma and csf levels are increased in mild Alzheimer’s disease, file dfa8b9a6-a396-748b-e053-3a05fe0a3a96
|
89
|
|
Looking at Alzheimer’s disease pathogenesis from the nuclear side, file dfa8b9a9-68ed-748b-e053-3a05fe0a3a96
|
82
|
|
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease, file f525a913-e257-451c-ac98-c02dc0253ac9
|
79
|
|
Proximity ligation assay reveals both pre- A nd postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain, file dfa8b9a2-35f9-748b-e053-3a05fe0a3a96
|
77
|
|
Editorial : Identification of Multiple Targets in the Fight Against Alzheimer's Disease, file dfa8b9a3-87f3-748b-e053-3a05fe0a3a96
|
65
|
|
Transcranial magnetic stimulation exerts “rejuvenation” effects on corticostriatal synapses after partial dopamine depletion, file dfa8b9a8-1baf-748b-e053-3a05fe0a3a96
|
62
|
|
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease, file dfa8b9aa-6360-748b-e053-3a05fe0a3a96
|
56
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file 38b90f05-c213-4f85-bcbc-be09e4dd0fb9
|
40
|
|
Novel therapeutic approaches to target neurodegeneration, file e3f98853-209e-4637-bdab-cf79db931539
|
29
|
|
Transcranial magnetic stimulation exerts “rejuvenation” effects on corticostriatal synapses after partial dopamine depletion, file ca35f809-0078-4653-a7ae-03436d49f211
|
19
|
|
Functional interdependence of the actin regulators CAP1 and cofilin1 in control of dendritic spine morphology, file d3d6b629-5750-4a67-8f76-b10aa0d6ee72
|
19
|
|
Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia : three faces of the same coin, file dfa8b99a-c6f1-748b-e053-3a05fe0a3a96
|
14
|
|
ATM rules neurodevelopment and glutamatergic transmission in the hippocampus but not in the cortex, file 82c9ab17-a369-4c6a-bf68-10e3d2d56236
|
13
|
|
Disease association of cyclase-associated protein (CAP): Lessons from gene-targeted mice and human genetic studies, file cac7710d-d2fb-4da0-8290-5aba9765402f
|
13
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file dfa8b99f-a398-748b-e053-3a05fe0a3a96
|
12
|
|
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients, file dfa8b9aa-736e-748b-e053-3a05fe0a3a96
|
12
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file 57f65534-4866-4e72-85fe-8bdc9066d0a2
|
11
|
|
The epilepsy-associated protein PCDH19 undergoes NMDA receptor-dependent proteolytic cleavage and regulates the expression of immediate-early genes, file d1644b39-9faf-4e63-89cc-d4c8ff312201
|
10
|
|
The Epilepsy-Related Protein PCDH19 Regulates Tonic Inhibition, GABA A R Kinetics, and the Intrinsic Excitability of Hippocampal Neurons, file adf4be14-c037-4531-871c-a02c9a5a9643
|
7
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file 94630b89-8648-4c24-a16b-d939ce118c7d
|
6
|
|
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects, file dfa8b995-0863-748b-e053-3a05fe0a3a96
|
6
|
|
Alzheimer's disease and modern lifestyle : what is the role of stress?, file dfa8b994-a270-748b-e053-3a05fe0a3a96
|
4
|
|
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease, file dfa8b99a-d075-748b-e053-3a05fe0a3a96
|
4
|
|
An association study of cyclase-associated protein 2 and frailty, file 9186fba6-cec4-4f92-925d-f55f4bf763b8
|
3
|
|
Synaptic dysfunction in Alzheimer's disease : from the role of amyloid β-peptide to the α-secretase ADAM10, file dfa8b99a-4ea0-748b-e053-3a05fe0a3a96
|
3
|
|
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability, file 9775e450-f364-4f39-8cea-d1b2bfd3a537
|
2
|
|
Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity, file dfa8b998-1491-748b-e053-3a05fe0a3a96
|
2
|
|
ADAM10 as a therapeutic target for brain diseases : from developmental disorders to Alzheimer's disease, file dfa8b999-ec7d-748b-e053-3a05fe0a3a96
|
2
|
|
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease, file dfa8b99b-b109-748b-e053-3a05fe0a3a96
|
2
|
|
New Views of the DNA Repair Protein Ataxia–Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases, file 604789bf-8b48-4cbd-956f-49031455968b
|
1
|
|
Beyond the unfolded protein response: Disclosing the role of XBP1s in Alzheimer’s disease, file d0ac3a37-8a1d-4e40-bcf0-ae665497777a
|
1
|
|
Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease, file dfa8b99a-25ba-748b-e053-3a05fe0a3a96
|
1
|
|
MicroRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease, file dfa8b99a-3e19-748b-e053-3a05fe0a3a96
|
1
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file dfa8b99f-e335-748b-e053-3a05fe0a3a96
|
1
|
|
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure., file dfa8b9a1-1b19-748b-e053-3a05fe0a3a96
|
1
|
|
Farmaci nella terapia della demenza di Alzheimer, file dfa8b9a3-f083-748b-e053-3a05fe0a3a96
|
1
|
|
Farmaci per il sistema nervoso centrale, file dfa8b9a4-208f-748b-e053-3a05fe0a3a96
|
1
|
|
Synaptic dysfunction in early phases of Alzheimer's Disease, file dfa8b9a9-1958-748b-e053-3a05fe0a3a96
|
1
|
| Totale |
4.509 |